Aurinia Pharmaceuticals
AUPH
#4611
Rank
โ‚ฌ1.76 B
Marketcap
13,40ย โ‚ฌ
Share price
2.02%
Change (1 day)
55.07%
Change (1 year)

Revenue for Aurinia Pharmaceuticals (AUPH)

Revenue in 2025 (TTM): โ‚ฌ0.23 Billion

According to Aurinia Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.22 Billion. In 2024 the company made a revenue of โ‚ฌ0.22 Billion an increase over the revenue in the year 2023 that were of โ‚ฌ0.15 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Aurinia Pharmaceuticals from 1999 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ0.23 B5%
2024 โ‚ฌ0.22 B42.32%
2023 โ‚ฌ0.15 B27.07%
2022 โ‚ฌ0.12 B210.29%
2021 โ‚ฌ40.26 M-1.17%
2020 โ‚ฌ40.74 M14253.98%
2019 โ‚ฌ0.28 M-29.86%
2018 โ‚ฌ0.4 M15.9%
2017 โ‚ฌ0.34 M112.32%
2016 โ‚ฌ0.16 M-23.48%
2015 โ‚ฌ0.21 M-5.97%
2014 โ‚ฌ0.22 M-66.76%
2013 โ‚ฌ0.68 M-85.03%
2012 โ‚ฌ4.59 M530.85%
2011 โ‚ฌ0.72 M-71.58%
2010 โ‚ฌ2.56 M33.49%
2009 โ‚ฌ1.91 M-31.46%
2008 โ‚ฌ2.79 M85.34%
2007 โ‚ฌ1.51 M-42.45%
2006 โ‚ฌ2.62 M-996.61%
2005 -โ‚ฌ0.3 Million-132.01%
2004 โ‚ฌ0.91 M-84.99%
2003 โ‚ฌ6.09 M-47.59%
2002 โ‚ฌ11.62 M
2000 โ‚ฌ0.94 M-29.94%
1999 โ‚ฌ1.34 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Regeneron Pharmaceuticals
REGN
โ‚ฌ12.22 B 5,260.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
โ‚ฌ5.42 M-97.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Pieris Pharmaceuticals
PIRS
โ‚ฌ16.79 M-92.64%๐Ÿ‡บ๐Ÿ‡ธ USA